Immunovant Stock Price History Breakdown

IMVT -  USA Stock  

USD 8.30  0.17  2.01%

Immunovant Stock price history is provided at the adjusted basis, taking into account all of the recent filings. As of today, the current price of Immunovant is  8.30 , as last reported on the 23rd of October, with the highest price reaching  8.51  and the lowest price hitting  8.00  during the day.
Immunovant holds Efficiency (Sharpe) Ratio of -0.0483, which attests that the entity had -0.0483% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Immunovant exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Immunovant risk adjusted performance of (0.01549), and Market Risk Adjusted Performance of (0.28) to validate the risk estimate we provide.

Immunovant Stock Price History 

 
Refresh
Net Income Common Stock is likely to drop to about (115.9 M) in 2021. Price to Book Value is likely to gain to 4.92 in 2021, whereas Price to Earnings Ratio are likely to drop (14.19)  in 2021.

Immunovant October 23, 2021 Stock Price Synopsis

Immunovant Price Action Indicator(0.04) 
Immunovant Accumulation Distribution 34,100 
Immunovant Price Daily Balance Of Power(0.33) 
Immunovant Price Rate Of Daily Change 0.98 
Share Download
When benchmark price declines in a down market, there may be an uptick in Immunovant Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Immunovant intraday prices and daily technical indicators to check the level of noise trading in Immunovant Stock and then apply it to test your longer-term investment strategies against Immunovant.

Immunovant Stock Price History Chart

There are several ways to analyze Immunovant Stock price data. The simplest method is using a basic Immunovant candlestick price chart, which shows Immunovant price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

90 Days Highest PriceJuly 30, 202110.46
90 Days Lowest PriceAugust 3, 20217.01

Immunovant Stock Price History Data

The price series of Immunovant for the period between Sun, Jul 25, 2021 and Sat, Oct 23, 2021 has a statistical range of 3.78 with a coefficient of variation of 9.13. Under current investment horizon, the daily prices are spread out with arithmetic mean of 8.72. The median price for the last 90 days is 8.69.
OpenHighLowCloseVolume
10/23/2021 8.44  8.51  8.00  8.30  569,000 
10/22/2021 8.44  8.47  8.00  8.30  563,545 
10/21/2021 8.54  8.74  8.45  8.47  302,800 
10/20/2021 8.81  8.95  8.48  8.53  302,100 
10/19/2021 8.63  9.02  8.61  8.81  407,545 
10/18/2021 8.68  8.96  8.43  8.57  423,800 
10/15/2021 9.33  9.33  8.66  8.72  498,600 
10/14/2021 9.37  9.54  9.11  9.22  390,700 
10/13/2021 9.30  9.46  9.13  9.32  312,000 
10/12/2021 9.12  9.35  9.01  9.30  397,600 
10/11/2021 9.04  9.41  8.85  9.12  718,000 
10/08/2021 8.95  9.09  8.82  9.02  225,200 
10/07/2021 8.93  9.20  8.80  9.01  644,000 
10/06/2021 8.91  8.97  8.71  8.92  554,800 
10/05/2021 8.79  9.06  8.74  8.98  492,700 
10/04/2021 8.75  8.98  8.60  8.78  691,400 
10/01/2021 8.78  8.95  8.49  8.83  549,700 
09/30/2021 8.82  8.97  8.61  8.69  350,500 
09/29/2021 9.10  9.32  8.77  8.82  537,200 
09/28/2021 8.92  9.23  8.80  9.03  538,400 
09/27/2021 8.69  9.00  8.40  8.97  724,200 
09/24/2021 8.78  8.84  8.61  8.65  347,000 
09/23/2021 8.88  8.88  8.39  8.82  457,200 
09/22/2021 8.75  8.96  8.69  8.74  490,000 
09/21/2021 8.70  8.79  8.55  8.65  402,000 
09/20/2021 8.69  8.80  8.43  8.61  630,800 
09/17/2021 8.42  8.89  8.41  8.82  1,584,100 
09/16/2021 8.47  8.51  8.21  8.49  486,400 
09/15/2021 8.48  8.64  8.37  8.53  442,400 
09/14/2021 8.65  8.66  8.33  8.50  532,700 
09/13/2021 8.64  8.85  8.39  8.69  566,600 
09/10/2021 8.98  8.99  8.62  8.62  462,600 
09/09/2021 8.94  9.00  8.62  8.96  583,700 
09/08/2021 8.73  9.03  8.73  8.95  555,600 
09/07/2021 8.93  9.05  8.54  8.84  504,500 
09/03/2021 9.29  9.32  8.87  9.01  584,600 
09/02/2021 8.90  9.30  8.84  9.26  908,700 
09/01/2021 8.70  8.92  8.61  8.82  729,500 
08/31/2021 8.32  8.67  8.30  8.66  961,100 
08/30/2021 8.71  8.91  8.28  8.35  997,100 
08/27/2021 8.30  8.42  8.19  8.40  667,400 
08/26/2021 8.35  8.54  8.26  8.32  436,600 
08/25/2021 8.20  8.75  8.13  8.46  843,000 
08/24/2021 8.45  8.45  8.02  8.21  513,200 
08/23/2021 8.07  8.44  7.91  8.31  1,468,600 
08/20/2021 7.35  7.98  7.29  7.85  643,600 
08/19/2021 7.72  7.83  7.31  7.33  753,900 
08/18/2021 7.80  8.22  7.70  7.76  2,271,500 
08/17/2021 7.59  7.94  7.35  7.85  1,022,300 
08/16/2021 7.98  7.98  7.41  7.50  943,400 
08/13/2021 8.13  8.16  7.86  7.88  860,900 
08/12/2021 8.17  8.20  7.98  8.14  635,900 
08/11/2021 8.17  8.22  7.85  8.11  940,100 
08/10/2021 7.90  8.18  7.79  8.09  1,087,400 
08/09/2021 7.72  8.02  7.61  7.78  1,018,400 
08/06/2021 7.80  7.90  7.59  7.75  1,039,900 
08/05/2021 7.44  7.86  7.24  7.77  1,841,700 
08/04/2021 7.04  7.64  7.01  7.36  3,073,200 
08/03/2021 7.72  7.73  6.68  7.01  8,745,400 
08/02/2021 8.53  9.07  7.70  7.74  10,686,100 
07/30/2021 10.66  10.78  10.31  10.46  441,700 

About Immunovant Stock history

Immunovant investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunovant is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunovant will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunovant historical stock prices may prove useful in developing a viable investing in Immunovant
Last ReportedProjected for 2021
Weighted Average Shares87.8 M75.7 M
Weighted Average Shares Diluted87.8 M75.7 M
Issuance Purchase of Equity Shares387.5 M418.1 M
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. Immunovant operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 68 people.

Immunovant Quarterly Market Capitalization

1.04 BillionShare

Immunovant Stock Technical Analysis

Immunovant technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunovant technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunovant trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Shere Portfolio Now

   

Shere Portfolio

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Immunovant Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Immunovant stock's direction in advance. Along with the technical and fundamental analysis of Immunovant Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunovant to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please see Risk vs Return Analysis. Note that the Immunovant information on this page should be used as a complementary analysis to other Immunovant's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Immunovant Stock analysis

When running Immunovant price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
The market value of Immunovant is measured differently than its book value, which is the value of Immunovant that is recorded on the company's balance sheet. Investors also form their own opinion of Immunovant's value that differs from its market value or its book value, called intrinsic value, which is Immunovant's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunovant's market value can be influenced by many factors that don't directly affect Immunovant underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunovant's value and its price as these two are different measures arrived at by different means. Investors typically determine Immunovant value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunovant's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.